|
Post by tchalaa on May 4, 2015 6:57:29 GMT -5
From Sanofi, "Afrezza will run $7.54 per day, based on a daily dose of 12 units." This leads us to a yearly cost of $2752,1
Since the production will be triple, from 162K patients per year to (166k*2)+162k = 494K patients per year It is obvious that, as soon as the 3 lines will reach their full year capacity, AFREZZA sales should generate at least $1,4Billions ~= (494k * $2752,1)
Now the 12-Units dose is coming as well as the 3-lines will be operating soon ... welcome December 2016
|
|